ME Therapeutics has garnered capital and advisory services from the National Research Council of Canada Industrial Research Assistance Program, the Vancouver-based preclinical biotechnology company announced this week. The Canadian therapeutics innovator is working on novel cancer fighting drugs in the field of immuno-oncology. ME Therapeutics’s proprietary mRNA sequences have been engineered to encode for proteins […]